All News

Temporary stand-in Ferdinando Nelli Feroci is quizzed on his priorities for the next four months

Diabetes, hydrogen-powered vehicles and electronics are among the diverse range of research to receive funding

The uncertainty sparked by the US ruling that the BRCA1 and BRCA2 breast cancer genes are not patentable is holding back the development of diagnostics and therapies, says patent lawyer Adrian Tombling

Taking a page out of nature’s handbook, Novozymes deploys enzymes to help (re) create a bio-based society

Commission is formed in the wake of critical analysis from the OECD and in the face of protests from French scientists

Commission's President-designate made the pledge in the European Parliament this week

A sole focus on computer simulation has been rejected by researchers, who say more basic research is needed before the brain can usefully be modelled in silico

The CEOs of Ablynx and uniQure, at a Science|Business event, tell their growth stories – and what Europe needs to do if there are to be more companies like theirs bringing new medicines to market

Pharmaceutical R&D functions at its best in small, agile and innovative SMEs. Replacing state subsidies and grant funding for research with start-up and development capital, would bring productivity improvements, says Mark Bloomfield, CEO of French biotech Polyplus Transfection

Winners of European Research Council Proof-of-Concept grants pitched their innovative ideas to investors and stakeholders at a Science|Business Innovation Board event last week.

Nigel Farage’s group shunned as two incumbents, Toia and Ransdorf re-appointed vice-chairs, and are joined by newcomers Henkel and Petersen

Former Prime Minister of Poland, Jerzy Buzek, is expected to be announced as chairman of ITRE next week

A new Science|Business report says Europe urgently needs to focus on energy market integration and flexibility

Horizon 2020 is not only the EU’s biggest, broadest and most ambitious R&D initiative ever, it is the first to prioritise innovation. Now, company culture must respond, boosting the quality, pace and scale of innovation, says Joachim von Heimburg

Poland must break down the silos between academics and industry, to build the trust and infrastructures needed to underpin multilateral collaborations, and enable Polish medical researchers to capitalise on pharma’s thirst for external innovation